SLC6A4
Sodium-dependent serotonin transporter
Also known as: 5-HTT, HTT, OCD1, SC6A4_HUMAN, SERT1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P31645
- Gene
- SLC6A4
- Ensembl
- ENSG00000108576
- Chromosome
- 17
- Canonical length
- 630 aa
- Protein class
- FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus,Vesicles
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
This gene encodes an integral membrane protein that transports the neurotransmitter serotonin from synaptic spaces into presynaptic neurons. The encoded protein terminates the action of serotonin and recycles it in a sodium-dependent manner. This protein is a target of psychomotor stimulants, such as amphetamines and cocaine, and is a member of the sodium:neurotransmitter symporter family. A repeat length polymorphism in the promoter of this gene has been shown to affect the rate of serotonin uptake. There have been conflicting results in the literature about the possible effect, if any, that this polymorphism may play in behavior and depression. [provided by RefSeq, May 2019]
Canonical amino-acid sequenceUniProt
630 residues, UniProt reviewed canonical sequence.
>P31645|SLC6A4
1 METTPLNSQK QLSACEDGED CQENGVLQKV VPTPGDKVES GQISNGYSAV PSPGAGDDTR
61 HSIPATTTTL VAELHQGERE TWGKKVDFLL SVIGYAVDLG NVWRFPYICY QNGGGAFLLP
121 YTIMAIFGGI PLFYMELALG QYHRNGCISI WRKICPIFKG IGYAICIIAF YIASYYNTIM
181 AWALYYLISS FTDQLPWTSC KNSWNTGNCT NYFSEDNITW TLHSTSPAEE FYTRHVLQIH
241 RSKGLQDLGG ISWQLALCIM LIFTVIYFSI WKGVKTSGKV VWVTATFPYI ILSVLLVRGA
301 TLPGAWRGVL FYLKPNWQKL LETGVWIDAA AQIFFSLGPG FGVLLAFASY NKFNNNCYQD
361 ALVTSVVNCM TSFVSGFVIF TVLGYMAEMR NEDVSEVAKD AGPSLLFITY AEAIANMPAS
421 TFFAIIFFLM LITLGLDSTF AGLEGVITAV LDEFPHVWAK RRERFVLAVV ITCFFGSLVT
481 LTFGGAYVVK LLEEYATGPA VLTVALIEAV AVSWFYGITQ FCRDVKEMLG FSPGWFWRIC
541 WVAISPLFLL FIICSFLMSP PQLRLFQYNY PYWSIILGYC IGTSSFICIP TYIAYRLIIT
601 PGTFKERIIK SITPETPTEI PCGDIRLNAVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC6A4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- small intestine: 38 nTPM
- lung: 27 nTPM
- placenta: 17 nTPM
- duodenum: 9.7 nTPM
- esophagus: 2.6 nTPM
- fallopian tube: 1.6 nTPM
Single-cell type
- cytotrophoblasts: 250 nCPM
- enterocytes: 156 nCPM
- syncytiotrophoblasts: 147 nCPM
- migrating cytotrophoblasts: 72 nCPM
- platelets: 63 nCPM
- vascular endothelial cells: 42 nCPM
Immune cell
- total PBMC: 0.3 nTPM
- neutrophil: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- midbrain: 508 nTPM
- pons: 183 nTPM
- medulla oblongata: 32 nTPM
- cerebellum: 1.1 nTPM
- cerebral cortex: 1 nTPM
- thalamus: 1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC6A4.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 148 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Obsessive-compulsive disorder
Disease | ImmuneIEDB
Conditions an epitope on SLC6A4 was assayed in.
- influenza T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.43
- gnomAD pLI
- 0.25
- gnomAD missense Z
- 1.93
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- amino acid transport
- behavioral response to cocaine
- brain morphogenesis
- cellular response to cGMP
- cellular response to retinoic acid
- circadian rhythm
- conditioned place preference
- enteric nervous system development
- male mating behavior
- membrane depolarization
- memory
- monoamine transport
- negative regulation of cerebellar granule cell precursor proliferation
- negative regulation of neuron differentiation
- negative regulation of organ growth
- negative regulation of synaptic transmission, dopaminergic
- neurotransmitter transport
- platelet aggregation
- positive regulation of cell cycle
- positive regulation of gene expression
- response to estradiol
- response to hypoxia
- response to nutrient
- response to toxic substance
- response to xenobiotic stimulus
- serotonin uptake
- sodium ion transmembrane transport
- vasoconstriction
- positive regulation of serotonin secretion
- regulation of thalamus size
Molecular functions
- actin filament binding
- antiporter activity
- identical protein binding
- integrin binding
- monoamine transmembrane transporter activity
- monoatomic cation channel activity
- neurotransmitter transmembrane transporter activity
- nitric-oxide synthase binding
- serotonin binding
- serotonin:sodium:chloride symporter activity
- sodium ion binding
- syntaxin-1 binding
- cocaine binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Sodium:neurotransmitter symporter
- Sodium:neurotransmitter symporter superfamily
- Sodium:neurotransmitter symporter family
- Sodium:neurotransmitter symporter, serotonin, N-terminal
- Serotonin (5-HT) neurotransmitter transporter, N-terminus
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SLC6A4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC6A4 as an antibody target. Whether an autoantibody or antibody against SLC6A4 could matter depends on whether native SLC6A4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC6A4 is annotated at the cell surface, where native SLC6A4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC6A4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...